Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 29934534.
- Also identified by DOI 10.1038/s41591-018-0100-0.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the version of this article originally published, some labels in Fig. 1f are incorrect. The "β-actin" labels on the second and fourth rows of blots should instead be "β-tubulin". The error has been corrected in the HTML and PDF versions of this article.